NASDAQ:TRNS - Transcat Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $21.70 -0.06 (-0.28 %) (As of 01/22/2019 11:18 AM ET)Previous Close$21.76Today's Range$21.70 - $21.7052-Week Range$13.40 - $25.35Volume100 shsAverage Volume15,673 shsMarket Capitalization$156.75 millionP/E Ratio30.30Dividend YieldN/ABeta0.75 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Transcat, Inc. provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; CalTrak Online, which provides its customers with Web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records; and Compliance, Control and Cost, a cloud-based customer portal and asset management tool. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs. This segment markets and sells its products through Website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including industrial manufacturing, oil and gas and alternative energy, aerospace and defense, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York. Receive TRNS News and Ratings via Email Sign-up to receive the latest news and ratings for TRNS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Instruments to measure electricity Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:TRNS Previous Symbol CUSIPN/A Webwww.transcat.com Phone585-352-7777Debt Debt-to-Equity Ratio0.42 Current Ratio2.00 Quick Ratio1.32Price-To-Earnings Trailing P/E Ratio30.30 Forward P/E Ratio21.70 P/E Growth2.73 Sales & Book Value Annual Sales$155.14 million Price / Sales1.01 Cash Flow$1.5589 per share Price / Cash Flow13.92 Book Value$7.18 per share Price / Book3.02Profitability EPS (Most Recent Fiscal Year)$0.71 Net Income$5.92 million Net Margins4.54% Return on Equity12.45% Return on Assets6.67%Miscellaneous Employees606 Outstanding Shares7,200,000Market Cap$156.75 million OptionableNot Optionable Transcat (NASDAQ:TRNS) Frequently Asked Questions What is Transcat's stock symbol? Transcat trades on the NASDAQ under the ticker symbol "TRNS." How were Transcat's earnings last quarter? Transcat, Inc. (NASDAQ:TRNS) posted its earnings results on Wednesday, May, 23rd. The scientific and technical instruments company reported $0.27 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.23 by $0.04. The scientific and technical instruments company earned $42.45 million during the quarter, compared to the consensus estimate of $40.70 million. Transcat had a net margin of 4.54% and a return on equity of 12.45%. View Transcat's Earnings History. When is Transcat's next earnings date? Transcat is scheduled to release their next quarterly earnings announcement on Monday, February 4th 2019. View Earnings Estimates for Transcat. What price target have analysts set for TRNS? 2 brokers have issued twelve-month price objectives for Transcat's shares. Their predictions range from $20.00 to $30.00. On average, they expect Transcat's stock price to reach $25.00 in the next year. This suggests a possible upside of 15.2% from the stock's current price. View Analyst Price Targets for Transcat. What is the consensus analysts' recommendation for Transcat? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Transcat. Has Transcat been receiving favorable news coverage? News articles about TRNS stock have trended very positive recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Transcat earned a daily sentiment score of 3.2 on InfoTrie's scale. They also assigned media stories about the scientific and technical instruments company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future. Who are some of Transcat's key competitors? Some companies that are related to Transcat include Allied Motion Technologies (AMOT), Exfo (EXFO), Frequency Electronics (FEIM), Data I/O (DAIO), Aehr Test Systems (AEHR), Giga-tronics (GIGA), Reliability (RLBY), Analogic (ALOG) and LTX-Credence (XCRA). Who are Transcat's key executives? Transcat's management team includes the folowing people: Mr. Lee D. Rudow, Pres, CEO & Director (Age 54)Mr. Michael J Tschiderer, VP of Fin., CFO, Treasurer & Corp. Sec. (Age 58)Mr. Robert A. Flack, VP of Service Sales & Operations (Age 48)Mr. Scott D. Deverell, Corp. Controller & Principal Accounting Officer (Age 52)Mr. Michael W. West, VP of Inside Sales & Marketing (Age 47) Who are Transcat's major shareholders? Transcat's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (3.19%) and QCI Asset Management Inc. NY (0.65%). Company insiders that own Transcat stock include Alan H Resnick, Angela J Panzarella, Carl E Sassano, Charles P Hadeed, Gary J Haseley, John T Smith, Michael Tschiderer, Paul D Moore and Robert A Flack. View Institutional Ownership Trends for Transcat. Which major investors are selling Transcat stock? TRNS stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co.. Company insiders that have sold Transcat company stock in the last year include Alan H Resnick, Charles P Hadeed and John T Smith. View Insider Buying and Selling for Transcat. Which major investors are buying Transcat stock? TRNS stock was acquired by a variety of institutional investors in the last quarter, including QCI Asset Management Inc. NY. Company insiders that have bought Transcat stock in the last two years include Angela J Panzarella, Gary J Haseley, Michael Tschiderer and Robert A Flack. View Insider Buying and Selling for Transcat. How do I buy shares of Transcat? Shares of TRNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Transcat's stock price today? One share of TRNS stock can currently be purchased for approximately $21.70. How big of a company is Transcat? Transcat has a market capitalization of $156.75 million and generates $155.14 million in revenue each year. The scientific and technical instruments company earns $5.92 million in net income (profit) each year or $0.71 on an earnings per share basis. Transcat employs 606 workers across the globe. What is Transcat's official website? The official website for Transcat is http://www.transcat.com. How can I contact Transcat? Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The scientific and technical instruments company can be reached via phone at 585-352-7777 or via email at [email protected] MarketBeat Community Rating for Transcat (NASDAQ TRNS)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 129 (Vote Outperform)Underperform Votes: 101 (Vote Underperform)Total Votes: 230MarketBeat's community ratings are surveys of what our community members think about Transcat and other stocks. Vote "Outperform" if you believe TRNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRNS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/22/2019 by MarketBeat.com StaffFeatured Article: How Do Front-End Loads Impact an Investment?